Fierce Pharma

CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix

The last available hemophilia gene therapy is temporarily unavailable, according to CSL Behring.  | The company is working ...
Healio

Q&A: ‘An exciting breakthrough’: Gene transfer therapy promising in Danon disease

Please provide your email address to receive an email when new articles are posted on . Danon cardiomyopathy is a rare but severe genetic disease that drastically reduces life expectancy. A novel gene ...
Morningstar

Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid ...

Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia PR Newswire ...
Nasdaq

Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND

Adaptimmune Therapeutics plc ADAP announced that British drugmaker GSK plc GSK has transferred the investigational new drug (IND) for T-cell therapy, letetresgene autoluecel (lete-cel), for the ...
ascopubs.org

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Thirty-five patients with metastatic melanoma, all but one with disease refractory to treatment with high-dose interleukin (IL) -2 and many with progressive disease after chemotherapy, underwent ...